Introduction
| Glycine Receptor Neurons | |
|---|---|
| Taxonomy | ID |
| Cell Ontology (CL) | [CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197) |
| Receptor Type | Glycine (GlyR α1-α3, β) |
| Family | Cys-loop receptor (ionotropic) |
| Signaling Mechanism | Ligand-gated Cl- channel, hyperpolarization |
| Primary Location | Spinal cord, brainstem, retina, hippocampus |
| Structure | Pentameric (typically α1β hetero-oligomer) |
| Kinetics | Very fast |
| Desensitization | Minimal |
| Primary location | Spinal cord/brainstem |
| Antagonist | Strychnine |
| Co-agonist | Taurine |
| Agent | Mechanism |
| Glycine | Agonist |
| Taurine | Partial agonist |
| Hypaerine | Positive modulator |
| Minocycline | GlyR enhancer |
Glycine Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
flowchart TD
cell_types_glycine_receptor_ne["Glycine Receptor Neurons"]
cell_types_glycine_receptor_ne["Introduction"]
cell_types_glycine_receptor_ne -->|"related to"| cell_types_glycine_receptor_ne
style cell_types_glycine_receptor_ne fill:#81c784,stroke:#333,color:#000
cell_types_glycine_receptor_ne["infobox-cell"]
cell_types_glycine_receptor_ne -->|"related to"| cell_types_glycine_receptor_ne
style cell_types_glycine_receptor_ne fill:#81c784,stroke:#333,color:#000
cell_types_glycine_receptor_ne["infobox-header"]
cell_types_glycine_receptor_ne -->|"related to"| cell_types_glycine_receptor_ne
style cell_types_glycine_receptor_ne fill:#81c784,stroke:#333,color:#000
cell_types_glycine_receptor_ne["label"]
cell_types_glycine_receptor_ne -->|"related to"| cell_types_glycine_receptor_ne
style cell_types_glycine_receptor_ne fill:#81c784,stroke:#333,color:#000
style cell_types_glycine_receptor_ne fill:#4fc3f7,stroke:#333,color:#000Glycine Receptor Neurons are neurons expressing the Glycine receptor, a member of the Glycine receptor family. These receptor neurons play crucial roles in motor neuron inhibition, reflex control, startle response and are implicated in various neurological and neurodegenerative conditions. 1Glycine receptor pharmacologyOpen reference
Multi-Taxonomy Classification
Taxonomy Database Cross-References
External Database Links
Receptor Properties
Function
Glycine Receptor Neurons are involved in motor neuron inhibition, reflex control, startle response, and auditory processing. These neurons express the Glycine receptor which functions as a ligand-gated Cl- channel, providing rapid inhibitory neurotransmission in the spinal cord, brainstem, retina, and hippocampus.
Glycine receptors are essential for:
-
Motor control: Inhibitory regulation of motor neurons
-
Respiratory control: Brainstem glycinergic neurons
-
Auditory processing: Sound localization via glycinergic inhibition
-
Reticular formation: Arousal and consciousness
Signaling Pathway
The Glycine receptor signals through ligand-gated Cl- channel, causing hyperpolarization of the neuron. This mechanism allows rapid inhibitory responses in motor circuits and sensory processing. Glycine receptors are antagonized by strychnine, a potent convulsant.
Comparison with GABA-A Receptors
Disease Implications
Glycine receptor dysfunction is implicated in several conditions:
-
Hyperekplexia: GLRA1 mutations cause startle disease
-
[Amyotrophic lateral sclerosis (ALS)amyotrophic-lateral-sclerosis): Loss of glycinergic inhibition in motor neurons
-
Alzheimer’s disease: Altered glycine receptor expression in hippocampus
-
Parkinson’s disease: Glycinergic signaling in basal ganglia
-
[Infantile neuroaxonal dystrophy (INAD)infantile-neuroaxonal-dystrophy): PLA2G6-related glycinergic dysfunction
-
[Hereditary spastic paraplegia (HSP)hereditary-spastic-paraplegia): Glycine receptor gene variants
-
Epilepsy: Glycinergic inhibition alterations
Role in Motor Neuron Disease
Glycine receptors are critical in motor neuron circuits:
-
Renshaw cell inhibition: Recurrent inhibitory circuits
-
Reciprocal inhibition: Antagonist muscle pairs
-
Presynaptic inhibition: Modulation of sensory input
-
Autaptic glycinergic currents: Self-inhibition
Therapeutic Targets
The Glycine receptor is a target for drug development in:
-
Neurological disorders: Epilepsy, spasticity
-
Neuropsychiatric conditions: Anxiety disorders, schizophrenia
-
Neurodegenerative diseases: ALS, Alzheimer’s disease
Pharmacological Approaches
See Also
Background
The study of Glycine Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
-
PubMed - Biomedical literature
-
Alzheimer’s Disease Neuroimaging Initiative - Research data
-
Allen Brain Atlas - Brain gene expression data
Pathway Diagram
The following diagram shows the key molecular relationships involving Glycine Receptor Neurons discovered through SciDEX knowledge graph analysis:
graph TD
Tat_NTS_peptide["Tat-NTS peptide"] -->|"protects against"| NEURONS["NEURONS"]
GLIA["GLIA"] -->|"interacts with"| NEURONS["NEURONS"]
TNF__["TNF-α"] -->|"induces"| NEURONS["NEURONS"]
MICROGLIA["MICROGLIA"] -->|"kills"| NEURONS["NEURONS"]
PRION_DISEASES["PRION DISEASES"] -->|"causes injury to"| NEURONS["NEURONS"]
CHRONIC_TRAUMATIC_ENCEPHALOPAT["CHRONIC TRAUMATIC ENCEPHALOPATHY"] -->|"causes injury to"| NEURONS["NEURONS"]
AUTOPHAGY["AUTOPHAGY"] -->|"preludes dysfunction"| NEURONS["NEURONS"]
__Synuclein["α-Synuclein"] -->|"interacts with"| NEURONS["NEURONS"]
ALZHEIMER_S["ALZHEIMER'S"] -->|"causes injury to"| NEURONS["NEURONS"]
MICROGLIA["MICROGLIA"] -->|"damages"| NEURONS["NEURONS"]
PARKINSON_S["PARKINSON'S"] -->|"causes injury to"| NEURONS["NEURONS"]
HUNTINGTON_S["HUNTINGTON'S"] -->|"causes injury to"| NEURONS["NEURONS"]
AMYOTROPHIC_LATERAL_SCLEROSIS["AMYOTROPHIC LATERAL SCLEROSIS"] -->|"causes injury to"| NEURONS["NEURONS"]
FRONTOTEMPORAL_DEMENTIA["FRONTOTEMPORAL DEMENTIA"] -->|"causes injury to"| NEURONS["NEURONS"]
AUTOPHAGY_FAILURE["AUTOPHAGY FAILURE"] -->|"heightens vulnerabil"| NEURONS["NEURONS"]
style Tat_NTS_peptide fill:#ff8a65,stroke:#333,color:#000
style NEURONS fill:#80deea,stroke:#333,color:#000
style GLIA fill:#80deea,stroke:#333,color:#000
style TNF__ fill:#4fc3f7,stroke:#333,color:#000
style MICROGLIA fill:#80deea,stroke:#333,color:#000
style PRION_DISEASES fill:#ef5350,stroke:#333,color:#000
style CHRONIC_TRAUMATIC_ENCEPHALOPAT fill:#ef5350,stroke:#333,color:#000
style AUTOPHAGY fill:#4fc3f7,stroke:#333,color:#000
style __Synuclein fill:#4fc3f7,stroke:#333,color:#000
style ALZHEIMER_S fill:#ef5350,stroke:#333,color:#000
style PARKINSON_S fill:#ef5350,stroke:#333,color:#000
style HUNTINGTON_S fill:#ef5350,stroke:#333,color:#000
style AMYOTROPHIC_LATERAL_SCLEROSIS fill:#ef5350,stroke:#333,color:#000
style FRONTOTEMPORAL_DEMENTIA fill:#ef5350,stroke:#333,color:#000
style AUTOPHAGY_FAILURE fill:#ffd54f,stroke:#333,color:#000References
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.